The Future of Addiction Treatment
“Ibogaine made them ready for change,” says researcher Deborah Mash, PhD. Mash has been studying the effects of ibogaine since 1992. A psychedelic compound derived from the bark of a shrub native to western central Africa, ibogaine is being used as a potent addiction disruptor (specifically for opioid use). Ibogaine may have the power to reset opioid tolerance and bypass many of the withdrawal symptoms that people endure when coming off of these drugs. Mash shares the extraordinary stories, people, and challenges behind the science, the studies, and the funding. And: what the future of ibogaine as a treatment for drug addiction might look like. (For more, see The goop Podcast hub.)
The Dark Night of the Soul
Releasing Emotional Blocks around Food
About The Show
goop CEO and founder Gwyneth Paltrow and longtime goop collaborator Erica Chidi, CEO and cofounder of LOOM, take turns hosting the brightest thinkers and culture changers.